Sanara MedTech Operating Income 2014-2024 | SMTI
Sanara MedTech operating income from 2014 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
| Sanara MedTech Annual Operating Income (Millions of US $) |
|
|---|---|
| 2023 | $-4 |
| 2022 | $-13 |
| 2021 | $-7 |
| 2020 | $-5 |
| 2019 | $-3 |
| 2018 | $0 |
| 2017 | $0 |
| 2016 | $-0 |
| 2015 | $-1 |
| 2014 | $-2 |
| 2013 | $-3 |
| Sanara MedTech Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2024-03-31 | $-2 |
| 2023-12-31 | $-0 |
| 2023-09-30 | $-1 |
| 2023-06-30 | $-2 |
| 2023-03-31 | $-1 |
| 2022-12-31 | $-3 |
| 2022-09-30 | $-3 |
| 2022-06-30 | $-3 |
| 2022-03-31 | $-3 |
| 2021-12-31 | $-3 |
| 2021-09-30 | $-2 |
| 2021-06-30 | $-1 |
| 2021-03-31 | $-1 |
| 2020-12-31 | $-1 |
| 2020-09-30 | $-1 |
| 2020-06-30 | $-1 |
| 2020-03-31 | $-2 |
| 2019-12-31 | $-1 |
| 2019-09-30 | $-1 |
| 2019-06-30 | $-0 |
| 2019-03-31 | $-0 |
| 2018-12-31 | $0 |
| 2018-09-30 | $0 |
| 2018-06-30 | $0 |
| 2018-03-31 | $0 |
| 2017-12-31 | $-0 |
| 2017-09-30 | $-0 |
| 2017-06-30 | $0 |
| 2017-03-31 | $0 |
| 2016-12-31 | |
| 2016-09-30 | |
| 2016-06-30 | $1 |
| 2016-03-31 | $1 |
| 2015-12-31 | |
| 2015-09-30 | $1 |
| 2015-06-30 | $1 |
| 2015-03-31 | |
| 2014-12-31 | |
| 2014-09-30 | |
| 2014-06-30 | |
| 2014-03-31 | |
| 2013-12-31 | |
| 2013-09-30 | |
| 2013-06-30 | |
| 2013-03-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.243B | $0.065B |
| Wound Management Technologies Inc. develops and markets wound care products. It develops, markets and distributes biotechnology products to physicians, hospitals and clinics. The Company markets collagen-based products for the treatment of pressure ulcers, diabetic ulcers, surgical wounds, ulcers due to arterial insufficiency, traumatic wounds, first and second degree burns and superficial wounds. It sells and distributes CellerateRX(R) Surgical Activated Collagen(R) Adjuvant as well as HemaQuell(R) Resorbable Bone Hemostat. Wound Management Technologies Inc. is based in Fort Worth, Texas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $180.765B | 23.67 |
| Stryker (SYK) | United States | $129.618B | 31.05 |
| Boston Scientific (BSX) | United States | $112.981B | 35.99 |
| Medtronic (MDT) | Ireland | $100.927B | 15.11 |
| EssilorLuxottica (ESLOY) | France | $99.128B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $40.585B | 0.00 |
| Haleon (HLN) | United Kingdom | $37.716B | 27.53 |
| ResMed (RMD) | United States | $28.121B | 26.40 |
| Terumo (TRUMY) | Japan | $24.403B | 34.46 |
| Koninklijke Philips (PHG) | Netherlands | $22.841B | 18.13 |
| Zimmer Biomet Holdings (ZBH) | United States | $22.328B | 14.26 |
| Baxter (BAX) | United States | $17.045B | 12.12 |
| Insulet (PODD) | United States | $14.134B | 62.67 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.833B | 0.00 |
| Demant (WILYY) | Denmark | $9.370B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.790B | 25.48 |
| BellRing Brands (BRBR) | United States | $7.453B | 35.06 |
| Lantheus Holdings (LNTH) | United States | $5.565B | 13.87 |
| GN Store Nord (GNNDY) | Denmark | $4.222B | 23.71 |
| Haemonetics (HAE) | United States | $4.215B | 20.79 |
| Perrigo (PRGO) | Ireland | $3.501B | 10.61 |
| Prestige Consumer Healthcare (PBH) | United States | $3.437B | 16.35 |
| Neogen (NEOG) | United States | $3.386B | 32.56 |
| ICU Medical (ICUI) | United States | $2.893B | 25.54 |
| Envista Holdings (NVST) | United States | $2.858B | 11.79 |
| TG Therapeutics (TGTX) | United States | $2.749B | 77.35 |
| Green Thumb Industries (GTBIF) | United States | $2.552B | 49.96 |
| Agios Pharmaceuticals (AGIO) | United States | $2.448B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.225B | 12.35 |
| LeMaitre Vascular (LMAT) | United States | $1.847B | 54.13 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.804B | 0.00 |
| Warby Parker (WRBY) | United States | $1.592B | 0.00 |
| InMode (INMD) | Israel | $1.532B | 8.14 |
| AdaptHealth (AHCO) | United States | $1.332B | 9.90 |
| Verano Holdings (VRNOF) | United States | $1.246B | 0.00 |
| AtriCure (ATRC) | United States | $1.084B | 0.00 |
| Owens & Minor (OMI) | United States | $1.033B | 9.00 |
| National Vision Holdings (EYE) | United States | $1.028B | 32.72 |
| BioLife Solutions (BLFS) | United States | $0.987B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.771B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.679B | 14.46 |
| Evolus (EOLS) | United States | $0.679B | 0.00 |
| PetIQ (PETQ) | United States | $0.656B | 21.21 |
| VAREX IMAGING (VREX) | United States | $0.602B | 14.16 |
| Surmodics (SRDX) | United States | $0.599B | 37.54 |
| Quanterix (QTRX) | United States | $0.506B | 0.00 |
| ZimVie (ZIMV) | United States | $0.498B | 42.44 |
| Canopy Growth (CGC) | Canada | $0.491B | 0.00 |
| Valneva SE (VALN) | France | $0.488B | 0.00 |
| Biote (BTMD) | United States | $0.463B | 10.67 |
| Jin Medical (ZJYL) | China | $0.403B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.394B | 0.00 |
| Cerus (CERS) | United States | $0.325B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.315B | 10.14 |
| Zynex (ZYXI) | United States | $0.296B | 40.52 |
| MacroGenics (MGNX) | United States | $0.266B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.254B | 25.19 |
| Aurora Cannabis (ACB) | Canada | $0.252B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.236B | 14.85 |
| Omeros (OMER) | United States | $0.235B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.233B | 0.00 |
| High Tide (HITI) | Canada | $0.178B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.160B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.153B | 21.76 |
| Capricor Therapeutics (CAPR) | United States | $0.153B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.150B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.137B | 0.00 |
| Veru (VERU) | United States | $0.123B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.110B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.104B | 0.00 |
| Fonar (FONR) | United States | $0.101B | 10.26 |
| Brainsway (BWAY) | Israel | $0.101B | 0.00 |
| InterCure (INCR) | Israel | $0.092B | 15.46 |
| Cellectar Biosciences (CLRB) | United States | $0.090B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.073B | 4.75 |
| MariMed (MRMD) | United States | $0.069B | 0.00 |
| Safety Shot (SHOT) | United States | $0.060B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.053B | 0.00 |
| Modular Medical (MODD) | United States | $0.051B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.049B | 0.00 |
| Bright Green (BGXX) | United States | $0.048B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.048B | 0.00 |
| Apyx Medical (APYX) | United States | $0.046B | 0.00 |
| United-Guardian (UG) | United States | $0.041B | 14.90 |
| Cytosorbents (CTSO) | United States | $0.038B | 0.00 |
| ImmuCell (ICCC) | United States | $0.038B | 0.00 |
| Exagen (XGN) | United States | $0.032B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.021B | 0.00 |
| Agape ATP (ATPC) | $0.016B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.016B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.012B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.011B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.007B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |